
TOKYO: Japan’s health ministry said Friday that it has signed a contract with US pharmaceutical giant Pfizer Inc. for supplies of its novel coronavirus vaccine from January 2022.
The Japanese government will receive an additional 120 million doses of the Pfizer vaccine.
According to the ministry, it plans to use the doses mainly for booster shots for people who have already been inoculated twice against COVID-19.
Earlier, the ministry had secured for next year 50 million coronavirus vaccine doses from US biotechnology company Moderna Inc., as well as 150 million doses of US biopharmaceutical firm Novavax Inc.’s vaccine, not yet approved in Japan.
JIJI Press